CD70 and diffuse large B-cell lymphoma: Kaplan-Meier analysis confirmed that high CD70 expression was significantly associated with poor prognosis in DLBCL patients treated in both the GSE10846 (Fig 4B) and GSE181063 (Fig 4C) cohorts.